The ChemoFx® assay: An ex vivo chemosensitivity and resistance assay for predicting patient response to cancer chemotherapy

Methods in Molecular Biology

Volumn 414, Issue , 2007, Pages 57-78

  Brower, Stacey L ^a   Fensterer, Jeffrey E ^a   Bush, Jason E ^a  

^a NONE

Author keywords

Cancer; Chemosensitivity and resistance assay (CSRA); Ex vivo chemoresponse; Personalized medicine; Primary tissue culture

Indexed keywords

EID: 37849017744     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (12)

1. Gallion, H., Christopherson, W. A., Coleman, R. L., et al. (2006) Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay. Int J Gynecol Cancer 16, 194-201.
2. Ness, R. B., Wisniewski, S. R., Eng, H., and Christopherson, W. (2002) Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response. Anticancer Res 22, 1145-1149.
3. Kornblith, P., Wells, A., Gabrin, M. J., et al. (2003) In vitro responses of ovarian cancer to platinums and taxanes. Anticancer Res 23, 543-548.
4. Kornblith, P., Wells, A., Gabrin, M. J., et al. (2003) Breast cancer-response rates to chemotherapeutic agents studied in vitro. Anticancer Res 23, 3405-3412.
5. Ochs, R. L., Fensterer, J., Ohori, N. P., et al. (2003) Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors. In Vitro Cell Dev Biol Anim 39, 63-70.
6. Ochs, R. L., Chattapadhyay, A., Bratton, R., et al. (2004) Phenotypic cell culture assay for predicting anticancer drug responses. Preclinica 2, 205-212.
7. Samson, D. J., Seidenfeld, J., Ziegler, K., et al. (2004) Chemotherapy sensitivity and resistance assays: a systematic review. J Clin Oncol 22, 3618-3630.
8. O'Meara, A. T., and Sevin, B.-U. (2001) Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer. Gynecol Oncol 83, 334-342.
9. Kern, D. H., and Weisenthal, L. M. (1990) Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures. J Natl Cancer Inst 82, 582-588.
10. Chu, E., and DeVita, V. T. Jr. (2001) In vitro drug response assays, in Cancer: Principles and Practice of Oncology (DeVita, V. T. Jr., Hellman, S., and Rosenberg, S. A., eds.), Lippincott, Williams & Wilkins, Philadelphia, PA, pp. 302-304.
11. Fruehauf, J. P. (2002) In vitro assay-assisted treatment selection for women with breast or ovarian cancer. Endocr. Relat. Cancer 9, 171-182.
12. Flowers, J. L., Ludeman, S. M., Gamcsik, M. P., et al. (2000) Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide. Cancer Chemother Pharmacol 45, 335-344.